Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
Efficacy of Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
Istanbul University
100 participants
Apr 15, 2023
INTERVENTIONAL
Conditions
Summary
The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing it to the results obtained from systematic lymphadenectomy, each performed in participants with a suspicious adnexal mass for early-stage ovarian cancer.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Described in previous sections
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05927818